EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results
May 08, 2018
|
EyePoint Pharmaceuticals Announces Third Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information
Apr 19, 2018
|
EyePoint Pharmaceuticals' YUTIQ™ for Posterior Segment Uveitis to be Presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Apr 18, 2018
|
EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™
Apr 12, 2018
|
pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners - Company Will Rebrand as EyePoint Pharmaceuticals, Inc.
Mar 28, 2018
|
pSivida Announces FDA Acceptance For Filing of New Drug Application (NDA) for Durasert™ Three-Year Treatment for Posterior Segment Uveitis
Mar 19, 2018
|
pSivida To Present at the 30th Annual ROTH Conference
Mar 05, 2018
|
pSivida to Present at the 2018 BIO CEO & Investor Conference
Feb 09, 2018
|
pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines
Feb 07, 2018
|
pSivida's Second Phase 3 Study for Durasert™ Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months
Feb 07, 2018
|
pSivida Corp. Announces Second Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information
Jan 24, 2018
|
pSivida Submits New Drug Application (NDA) for Durasert™ Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA
Jan 08, 2018
|
pSivida Granted Waiver by the FDA for New Drug Application Filing Fee
Jan 04, 2018
|
pSivida to Present at the Annual Biotech Showcase Conference
Jan 02, 2018
|
HSS and pSivida Report Positive Phase 1 Knee Osteoarthritis Pain Study Data
Dec 14, 2017
|
pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution
Nov 07, 2017
|
pSivida Corp. Announces First Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information
Oct 18, 2017
|
pSivida and Nicox Enter Strategic Collaboration Agreement to Develop Sustained Release Drug to Lower Intraocular Pressure in Patients with Glaucoma
Oct 10, 2017
|
pSivida Partners with Global Pharmaceuticals Company to Develop Sustained Release Formulations of Glaucoma Drugs
Sep 26, 2017
|
pSivida to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 22, 2017
|